Corneal Storage Fluid with Fungus Fighters Reclassified
Published Date: 5/6/2026
Rule
Summary
The FDA is officially putting corneal storage fluids with preservatives and antifungals into a safer, easier-to-manage category called Class II. This change helps make sure these eye care products are safe and effective while speeding up access to new, helpful devices. Starting May 6, 2026, companies will follow these new rules, which could save time and money by cutting down on red tape.
Analyzed Economic Effects
3 provisions identified: 2 benefits, 0 costs, 1 mixed.
Class II listing may speed patient access
The FDA officially classified corneal storage medium with preservatives including antifungals as Class II (special controls). This change is effective May 6, 2026 (and was applicable May 2, 2022) and the agency says the change will enhance patients' access to beneficial innovative devices by reducing regulatory burdens while providing reasonable assurance of safety and effectiveness.
Manufacturers must meet special controls and 510(k)
Corneal storage media with preservatives including antifungals are Class II devices and therefore subject to premarket notification under section 510(k). Manufacturers must comply with the listed special controls (for example: non-clinical performance testing, sterility demonstration, biocompatibility, shelf life testing, packaging compatibility, antimicrobial resistance analysis, and labeling), so companies will need to perform these tests and include required information when seeking market clearance.
Creates a predicate for future devices
FDA states that when it classifies a device into Class II via the De Novo process, the device can serve as a predicate for future devices of that type, allowing other sponsors to use the less-burdensome 510(k) process rather than De Novo or premarket approval. This makes it easier for subsequent corneal storage media products to seek market clearance using the 510(k) pathway.
Personalized for You
How does this regulation affect your finances?
Personalize government policy and PRIA will tell you what this federal register document means for your household, plus every other regulation we track. PRIA reads each provision against your financial profile to show you exactly what matters to your wallet.
Key Dates
Department and Agencies
Related Federal Register Documents
2026-16296, Substances Generally Recognized as Safe
The Food and Drug Administration (FDA or we) is proposing to require the submission of generally recognized as safe (GRAS) notices for the use of a human or animal food substance purported to be GRAS under the conditions of its intended use under the Federal Food, Drug, and Cosmetic Act (FD&C Act).
2026-14073, Drug Establishment Registration and Drug Listing Requirements for Establishments Engaged in Distributed Manufacturing and Certain Foreign Establishments
The FDA wants to make it easier for drug makers who work in several locations to register as one company instead of many. They’re also updating rules for foreign drug companies to match new laws about handling health threats. If you’re in drug manufacturing, get ready to comment by September 11, 2026, and keep an eye on possible paperwork changes that could affect your business.
2026-13047, Establishment Registration and Product Listing for Tobacco Products
The FDA wants to make sure all tobacco product makers, both in the U.S. and abroad, register their businesses and list their products. This new rule closes a big gap by including foreign companies, helping the FDA keep better track of tobacco products for public health. Comments on this proposal are open until September 14, 2026, so affected businesses should get ready to update their info and possibly face new costs.
2026-16728, Gastroenterology-Urology Devices; Reclassification of Diagnostic Endoscopic Light Source Systems To Be Renamed Cystoscopic Systems Intended as an Aid for Detection of Bladder Cancer
The Food and Drug Administration (FDA) is proposing to reclassify diagnostic endoscopic light source systems (product code OAY), which are postamendments class III devices, from class III (premarket approval) into class II (special controls), subject to premarket notification. FDA is also proposing a new device classification regulation with the name "Cystoscopic system intended as an aid for detection of bladder cancer," along with special controls that FDA believes are necessary to provide a reasonable assurance of the safety and effectiveness of these devices.
2026-16712, Agency Information Collection Activities; Proposed Collection; Comment Request; Imports and Electronic Import Entries
The FDA wants your thoughts on how they collect info about imports and electronic import entries. If you’re involved in importing goods, this could affect you! They’re asking for comments by October 16, 2026, to help improve the process without adding extra costs or hassle.
2026-16727, Hematology and Pathology Devices; Reclassification of In Situ Hybridization Test Systems for Use With a Corresponding Approved Oncology Therapeutic Product
The Food and Drug Administration (FDA, the Agency, or we) is issuing a final order reclassifying in situ hybridization (ISH) test systems indicated for use with a corresponding approved oncology therapeutic product (product codes NYQ, MVD, OWE, and PNK), all postamendments class III (premarket approval) devices, into class II (special controls), subject to premarket notification. FDA is also establishing a new device classification regulation, along with the special controls that are necessary to provide a reasonable assurance of safety and effectiveness of this device type.
Previous / Next Documents
Previous: 2026-08812, Medical Devices; Immunology and Microbiology Devices; Classification of the Circulating Tumor Cell Enrichment Device
The FDA is officially classifying the circulating tumor cell enrichment device as a Class II device, meaning it has special safety rules but fewer hurdles than the strictest category. This change helps patients get access to innovative cancer-fighting tools faster and keeps the device safe and effective. The new rules take effect May 6, 2026, and could save time and money for makers and users of this device.
Next: 2026-08822, Safety Zone; Key West Paddle Classic, Key West, FL
On May 9, 2026, the Coast Guard will set up a temporary safety zone around Key West for the Key West Paddle Classic, where about 100 paddleboarders will race. Boats and people can’t enter this zone unless they get special permission, keeping everyone safe during the event. This rule only lasts from 6 a.m. to 5 p.m. and doesn’t cost anyone money but means boaters need to plan ahead.